Skip to main content
Clinical Trials/NCT02885701
NCT02885701
Completed
Not Applicable

A Prospective, Randomized Controlled Study of Splinting After Mini-Open Carpal Tunnel Release

Anthony L. Logli0 sites249 target enrollmentDecember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carpal Tunnel Syndrome
Sponsor
Anthony L. Logli
Enrollment
249
Primary Endpoint
Levine-Katz Symptom Severity Scale (SSS)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine if any difference exists among 3 different postoperative splinting regimens- no splint, removable splint, and plaster non-removable splint- following mini-open carpal tunnel release (CTR) surgery.

Detailed Description

We sought to determine if any significant difference in patient-reported or clinical outcomes existed among 3 different postoperative splinting regimens- no splint, removable splint, and plaster non-removable splint- following mini-open carpal tunnel release (CTR) surgery for symptomatic, isolated, nerve conduction study positive carpal tunnel syndrome (CTS). A total of 249 patients received a mini-open CTR and were subsequently randomized into 1 of the 3 splinting regimens to be removed at the first postoperative visit 10-14 days later. Patient-reported outcomes included QuickDASH surveys, Levine-Katz Symptom Severity Scale (SSS) and Functional Status Scale (FSS) and Pain at Rest and in Action using a Numerical Pain Rating Scale (NPRS). Clinical outcomes included wrist range of motion (ROM), grip and lateral pinch strengths. All outcomes were evaluated bilaterally at 10-14 days, 6 weeks, 3 months, 6 months and 12 months after surgery. Demographic information was obtained preoperatively and complications were observed for and recorded throughout the study

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
January 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Anthony L. Logli
Responsible Party
Sponsor Investigator
Principal Investigator

Anthony L. Logli

Student Doctor

OrthoIllinois

Eligibility Criteria

Inclusion Criteria

  • Patients were required to have failed conservative treatment for symptomatic, isolated, nerve conduction study positive CTS.

Exclusion Criteria

  • Exclusion criteria omitted patients who presented with acute onset CTS, concomitant peripheral neuropathy, metabolic disease, postoperative recurring CTS, or who required another operative procedure during carpal tunnel release.

Outcomes

Primary Outcomes

Levine-Katz Symptom Severity Scale (SSS)

Time Frame: 10-14 days postoperatively

The Levine-Katz Symptom Severity Scale (SSS) assesses pain, weakness, and sensation with 11 questions the patient rates on a 5-point scale with 5 indicating the most difficult; the average score is reported.

QuickDASH

Time Frame: 10-14 days postoperatively

The Quick Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure was designed in 1998 with the goal of providing a more accurate depiction of the everyday symptoms and handicaps exclusively experienced by a patient with an upper extremity musculoskeletal condition. Designed as a patient-completed questionnaire, the DASH Outcome Measure can be administered multiple times throughout patient care to measure changes in function and symptoms over time

Lateral Pinch Strength

Time Frame: 10-14 days postoperatively

Lateral pinch strength was taken with a Preston Pinch Gauge.

Grip Strength

Time Frame: 10-14 days postoperatively

Grip strength was taken with a Jamar Dynamometer in the 2nd hand position.

Numerical Pain Rating Scale

Time Frame: 10-14 days postoperatively

Patients are asked to describe their level of pain intensity over the last 24 hours. The pain scale anchor points 0 and 10 correspond to no pain and worst imaginable pain, respectively. The NPRS can be used multiple times throughout patient care, but has the greatest value in describing post-operative pain-related morbidity.

Wrist Flexion

Time Frame: 10-14 days postoperatively

Secondary Outcomes

  • Complications(10-14 days postoperatively)
  • Demographic Information(Preoperatively)

Similar Trials